

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.75425336 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.75425336 |
| 3 | intestinal cholesterol absorption (GO:0030299) | 5.53729960 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.22301162 |
| 5 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.79977652 |
| 6 | exocrine pancreas development (GO:0031017) | 4.72684733 |
| 7 | protein retention in ER lumen (GO:0006621) | 4.62614023 |
| 8 | * positive regulation of nuclease activity (GO:0032075) | 4.60224748 |
| 9 | nuclear pore complex assembly (GO:0051292) | 4.46032518 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44157881 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.43048954 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.43048954 |
| 13 | * regulation of nuclease activity (GO:0032069) | 4.20576033 |
| 14 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.16357661 |
| 15 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.15578082 |
| 16 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 4.12703684 |
| 17 | COPII vesicle coating (GO:0048208) | 4.05400565 |
| 18 | histone H3-K36 demethylation (GO:0070544) | 4.04091460 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.00348497 |
| 20 | * cellular response to unfolded protein (GO:0034620) | 3.99391904 |
| 21 | * ER-nucleus signaling pathway (GO:0006984) | 3.85833812 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.85651265 |
| 23 | nuclear pore organization (GO:0006999) | 3.74213114 |
| 24 | T cell lineage commitment (GO:0002360) | 3.72064616 |
| 25 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.71299411 |
| 26 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.70541455 |
| 27 | * cellular response to topologically incorrect protein (GO:0035967) | 3.66860573 |
| 28 | * response to endoplasmic reticulum stress (GO:0034976) | 3.62116593 |
| 29 | germinal center formation (GO:0002467) | 3.61795556 |
| 30 | positive regulation of histone deacetylation (GO:0031065) | 3.57070988 |
| 31 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.55731980 |
| 32 | cellular response to ethanol (GO:0071361) | 3.55317175 |
| 33 | B cell homeostasis (GO:0001782) | 3.53459610 |
| 34 | B cell receptor signaling pathway (GO:0050853) | 3.51778789 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 3.51242844 |
| 36 | positive thymic T cell selection (GO:0045059) | 3.48777289 |
| 37 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.48535045 |
| 38 | vesicle coating (GO:0006901) | 3.43750070 |
| 39 | protein localization to endosome (GO:0036010) | 3.34884143 |
| 40 | intestinal absorption (GO:0050892) | 3.33679457 |
| 41 | digestion (GO:0007586) | 3.31336656 |
| 42 | B cell proliferation (GO:0042100) | 3.27419287 |
| 43 | negative regulation of bone resorption (GO:0045779) | 3.23301021 |
| 44 | pore complex assembly (GO:0046931) | 3.22642049 |
| 45 | transcytosis (GO:0045056) | 3.19557705 |
| 46 | mannose metabolic process (GO:0006013) | 3.16445081 |
| 47 | T cell migration (GO:0072678) | 3.14209578 |
| 48 | * response to unfolded protein (GO:0006986) | 3.02560566 |
| 49 | intestinal epithelial cell development (GO:0060576) | 3.02484439 |
| 50 | response to muramyl dipeptide (GO:0032495) | 2.99048247 |
| 51 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.96138100 |
| 52 | positive regulation of tolerance induction (GO:0002645) | 2.94536757 |
| 53 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.93343333 |
| 54 | L-serine transport (GO:0015825) | 2.93306667 |
| 55 | peptidyl-asparagine modification (GO:0018196) | 2.92135676 |
| 56 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.91717355 |
| 57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91272581 |
| 58 | * endocrine pancreas development (GO:0031018) | 2.91101425 |
| 59 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.91063943 |
| 60 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.90686435 |
| 61 | 4-hydroxyproline metabolic process (GO:0019471) | 2.88008135 |
| 62 | serine transport (GO:0032329) | 2.86988718 |
| 63 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.86267897 |
| 64 | positive T cell selection (GO:0043368) | 2.86012124 |
| 65 | regulation of RNA export from nucleus (GO:0046831) | 2.85649845 |
| 66 | glomerular epithelial cell development (GO:0072310) | 2.85266915 |
| 67 | positive regulation of Rap GTPase activity (GO:0032854) | 2.84742801 |
| 68 | * response to topologically incorrect protein (GO:0035966) | 2.83078902 |
| 69 | embryonic process involved in female pregnancy (GO:0060136) | 2.82061297 |
| 70 | negative regulation of B cell proliferation (GO:0030889) | 2.81165205 |
| 71 | gonadal mesoderm development (GO:0007506) | 2.80657448 |
| 72 | cellular response to antibiotic (GO:0071236) | 2.78451890 |
| 73 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.77686662 |
| 74 | positive regulation of protein homooligomerization (GO:0032464) | 2.77482571 |
| 75 | regulation of B cell proliferation (GO:0030888) | 2.75183545 |
| 76 | myelin maintenance (GO:0043217) | 2.73851092 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73091773 |
| 78 | tolerance induction (GO:0002507) | 2.71942154 |
| 79 | negative regulation of humoral immune response (GO:0002921) | 2.70206223 |
| 80 | protein targeting to Golgi (GO:0000042) | 2.67071548 |
| 81 | protein N-linked glycosylation (GO:0006487) | 2.65622246 |
| 82 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.64073028 |
| 83 | valine metabolic process (GO:0006573) | 2.62973895 |
| 84 | peptidyl-proline hydroxylation (GO:0019511) | 2.61468407 |
| 85 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.60908468 |
| 86 | histone lysine demethylation (GO:0070076) | 2.60506211 |
| 87 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.59015621 |
| 88 | Golgi organization (GO:0007030) | 2.58402565 |
| 89 | response to type I interferon (GO:0034340) | 2.57798865 |
| 90 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.57457595 |
| 91 | regulation of histone H3-K27 methylation (GO:0061085) | 2.57347037 |
| 92 | positive regulation of interferon-alpha production (GO:0032727) | 2.57292018 |
| 93 | positive regulation of B cell differentiation (GO:0045579) | 2.56446956 |
| 94 | regulation of extracellular matrix disassembly (GO:0010715) | 2.56382083 |
| 95 | cellular response to type I interferon (GO:0071357) | 2.56343307 |
| 96 | type I interferon signaling pathway (GO:0060337) | 2.56343307 |
| 97 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.56175176 |
| 98 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.54328360 |
| 99 | negative regulation of bone remodeling (GO:0046851) | 2.52924093 |
| 100 | positive regulation of protein oligomerization (GO:0032461) | 2.52142108 |
| 101 | regulation of cholesterol homeostasis (GO:2000188) | 2.51831408 |
| 102 | activation of MAPKKK activity (GO:0000185) | 2.51424209 |
| 103 | vesicle targeting (GO:0006903) | 2.51242906 |
| 104 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.50145860 |
| 105 | sequestering of metal ion (GO:0051238) | 2.48911864 |
| 106 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.48808383 |
| 107 | establishment of protein localization to Golgi (GO:0072600) | 2.48310403 |
| 108 | negative regulation of cell killing (GO:0031342) | 2.48027912 |
| 109 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.48027912 |
| 110 | Rap protein signal transduction (GO:0032486) | 2.47910500 |
| 111 | histone demethylation (GO:0016577) | 2.47659187 |
| 112 | positive regulation of p38MAPK cascade (GO:1900745) | 2.47317234 |
| 113 | regulation of fibroblast apoptotic process (GO:2000269) | 2.47145219 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 2.45917277 |
| 115 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.45686162 |
| 116 | macroautophagy (GO:0016236) | 2.45243444 |
| 117 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.44866971 |
| 118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44852020 |
| 119 | growth hormone receptor signaling pathway (GO:0060396) | 2.44785177 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 2.44336441 |
| 121 | * ER overload response (GO:0006983) | 2.43261398 |
| 122 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.42386106 |
| 123 | positive regulation of B cell proliferation (GO:0030890) | 2.41660653 |
| 124 | regulation of tolerance induction (GO:0002643) | 2.40785116 |
| 125 | negative thymic T cell selection (GO:0045060) | 2.39685487 |
| 126 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.39029553 |
| 127 | cellular response to glucose starvation (GO:0042149) | 2.37405050 |
| 128 | NIK/NF-kappaB signaling (GO:0038061) | 2.37374350 |
| 129 | regulation of ARF protein signal transduction (GO:0032012) | 2.36782666 |
| 130 | receptor catabolic process (GO:0032801) | 2.35776300 |
| 131 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.35519543 |
| 132 | apoptotic cell clearance (GO:0043277) | 2.35371418 |
| 133 | stress granule assembly (GO:0034063) | 2.35327846 |
| 134 | response to laminar fluid shear stress (GO:0034616) | 2.35227857 |
| 135 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.34378977 |
| 136 | myeloid dendritic cell differentiation (GO:0043011) | 2.33918639 |
| 137 | response to peptidoglycan (GO:0032494) | 2.33322030 |
| 138 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.32889513 |
| 139 | histone H3-K9 demethylation (GO:0033169) | 2.32861726 |
| 140 | zinc ion transport (GO:0006829) | 2.32677607 |
| 141 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.31768106 |
| 142 | response to interleukin-15 (GO:0070672) | 2.31654470 |
| 143 | germ cell migration (GO:0008354) | 2.31388242 |
| 144 | hepatocyte apoptotic process (GO:0097284) | 2.31072064 |
| 145 | lymphocyte homeostasis (GO:0002260) | 2.30703749 |
| 146 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.30451545 |
| 147 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.30431770 |
| 148 | positive regulation of interleukin-2 production (GO:0032743) | 2.30122797 |
| 149 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.29757582 |
| 150 | protein maturation by protein folding (GO:0022417) | 2.29538286 |
| 151 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.29352764 |
| 152 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.29260770 |
| 153 | sphingosine metabolic process (GO:0006670) | 2.28373269 |
| 154 | negative T cell selection (GO:0043383) | 2.28305107 |
| 155 | protein hydroxylation (GO:0018126) | 2.25970453 |
| 156 | V(D)J recombination (GO:0033151) | 2.24517113 |
| 157 | myeloid dendritic cell activation (GO:0001773) | 2.24399840 |
| 158 | negative regulation of fatty acid transport (GO:2000192) | 2.24209238 |
| 159 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.23895274 |
| 160 | detection of other organism (GO:0098543) | 2.21068975 |
| 161 | T cell costimulation (GO:0031295) | 2.19877054 |
| 162 | positive regulation of developmental pigmentation (GO:0048087) | 2.19851548 |
| 163 | cellular response to interleukin-15 (GO:0071350) | 2.19286718 |
| 164 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.18512119 |
| 165 | positive regulation of humoral immune response (GO:0002922) | 2.18298303 |
| 166 | T cell homeostasis (GO:0043029) | 2.18054740 |
| 167 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.16563187 |
| 168 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.16063813 |
| 169 | oligosaccharide catabolic process (GO:0009313) | 2.15166293 |
| 170 | lymphocyte costimulation (GO:0031294) | 2.14935569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.58035412 |
| 2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.70000079 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.49482766 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.18104144 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84047971 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77477105 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.75829931 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.51495606 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.44357297 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.43049077 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.40696016 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.36445535 |
| 13 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.25934492 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.17992047 |
| 15 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.11473109 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07890501 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07212388 |
| 18 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.05939897 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.97066632 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.95327278 |
| 21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92521432 |
| 22 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90900409 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.88096830 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88063682 |
| 25 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.87849500 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.85813303 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.83534610 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.79126213 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75455324 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.75053640 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70749785 |
| 32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.68329410 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68218340 |
| 34 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.68029174 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66820894 |
| 36 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.66504949 |
| 37 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.66504949 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.65345516 |
| 39 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.64015977 |
| 40 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.62594370 |
| 41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.61604124 |
| 42 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61104307 |
| 43 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.60972459 |
| 44 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.60801950 |
| 45 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.60019418 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59631218 |
| 47 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.58578175 |
| 48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.57274148 |
| 49 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55775915 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55520445 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55445174 |
| 52 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53884596 |
| 53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53662594 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51534981 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50769309 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50658446 |
| 57 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.48537535 |
| 58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.45916377 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44895002 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41309659 |
| 61 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41113560 |
| 62 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.39839397 |
| 63 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.35467067 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.34742653 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33480801 |
| 66 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32563225 |
| 67 | MAF_26560356_Chip-Seq_TH1_Human | 1.31907739 |
| 68 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31080311 |
| 69 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.31005866 |
| 70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30628721 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29147014 |
| 72 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28738411 |
| 73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26189639 |
| 74 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.24383579 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23803453 |
| 76 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.23548039 |
| 77 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.23409661 |
| 78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.20966723 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20881351 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20528287 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19720402 |
| 82 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.19654011 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18507537 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17771218 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17771018 |
| 86 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.17381852 |
| 87 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17293040 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16544134 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15000094 |
| 90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14876522 |
| 91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14205095 |
| 92 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.13989296 |
| 93 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.13888460 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12775758 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11149790 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11108020 |
| 97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10045143 |
| 98 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09513826 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07575996 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07434758 |
| 101 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.07073574 |
| 102 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06771174 |
| 103 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05932486 |
| 104 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05338525 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03136957 |
| 106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02866290 |
| 107 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.02650806 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02451441 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02313120 |
| 110 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02124488 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01410859 |
| 112 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01191525 |
| 113 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.00718171 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00269714 |
| 115 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00010352 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98978295 |
| 117 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.98077900 |
| 118 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97770227 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97218685 |
| 120 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96378080 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96310007 |
| 122 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95277744 |
| 123 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.95039921 |
| 124 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94442479 |
| 125 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94022487 |
| 126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93773996 |
| 127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93253747 |
| 128 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93036461 |
| 129 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91125531 |
| 130 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.89413333 |
| 131 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.89361987 |
| 132 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88373075 |
| 133 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.88341613 |
| 134 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87705141 |
| 135 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87595568 |
| 136 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.85819155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 4.04226298 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.53077269 |
| 3 | * MP0001666_abnormal_nutrient_absorption | 3.43320756 |
| 4 | MP0005083_abnormal_biliary_tract | 3.08267121 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 3.03653528 |
| 6 | MP0008057_abnormal_DNA_replication | 2.99170888 |
| 7 | * MP0005220_abnormal_exocrine_pancreas | 2.75161711 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.74699531 |
| 9 | MP0005365_abnormal_bile_salt | 2.74648235 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 2.55419705 |
| 11 | MP0003303_peritoneal_inflammation | 2.44921565 |
| 12 | MP0005451_abnormal_body_composition | 2.34190248 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.32682475 |
| 14 | MP0002009_preneoplasia | 2.27623607 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.16412336 |
| 16 | MP0006054_spinal_hemorrhage | 2.15730620 |
| 17 | * MP0002693_abnormal_pancreas_physiology | 2.13754744 |
| 18 | * MP0001944_abnormal_pancreas_morphology | 2.04293034 |
| 19 | MP0008961_abnormal_basal_metabolism | 2.02575161 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.02221579 |
| 21 | MP0001790_abnormal_immune_system | 1.96472847 |
| 22 | MP0005387_immune_system_phenotype | 1.96472847 |
| 23 | MP0002166_altered_tumor_susceptibility | 1.96079623 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 1.88706481 |
| 25 | MP0003045_fibrosis | 1.82504700 |
| 26 | MP0005671_abnormal_response_to | 1.81722393 |
| 27 | * MP0003868_abnormal_feces_composition | 1.78146806 |
| 28 | MP0001800_abnormal_humoral_immune | 1.75896675 |
| 29 | MP0004185_abnormal_adipocyte_glucose | 1.68418331 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.65818516 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.65589798 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.63685446 |
| 33 | MP0005310_abnormal_salivary_gland | 1.62396999 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.61479965 |
| 35 | MP0009785_altered_susceptibility_to | 1.59352764 |
| 36 | MP0002928_abnormal_bile_duct | 1.58201896 |
| 37 | MP0003252_abnormal_bile_duct | 1.57416128 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.56490398 |
| 39 | MP0000685_abnormal_immune_system | 1.54375026 |
| 40 | MP0000003_abnormal_adipose_tissue | 1.53978094 |
| 41 | MP0004947_skin_inflammation | 1.52361398 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.45858037 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.43548710 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.38964793 |
| 45 | MP0003283_abnormal_digestive_organ | 1.38812673 |
| 46 | MP0005085_abnormal_gallbladder_physiolo | 1.36602758 |
| 47 | MP0002254_reproductive_system_inflammat | 1.35660333 |
| 48 | MP0005025_abnormal_response_to | 1.33762467 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.33160795 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.30980837 |
| 51 | MP0003091_abnormal_cell_migration | 1.30748144 |
| 52 | MP0002722_abnormal_immune_system | 1.28828410 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.27857243 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.27537962 |
| 55 | MP0004043_abnormal_pH_regulation | 1.25604991 |
| 56 | MP0005375_adipose_tissue_phenotype | 1.24127402 |
| 57 | MP0002168_other_aberrant_phenotype | 1.22697058 |
| 58 | MP0002429_abnormal_blood_cell | 1.20960446 |
| 59 | MP0001835_abnormal_antigen_presentation | 1.20834266 |
| 60 | MP0009643_abnormal_urine_homeostasis | 1.19744786 |
| 61 | MP0003866_abnormal_defecation | 1.16727173 |
| 62 | MP0000609_abnormal_liver_physiology | 1.14325677 |
| 63 | MP0005000_abnormal_immune_tolerance | 1.14110585 |
| 64 | MP0005360_urolithiasis | 1.13885048 |
| 65 | MP0003941_abnormal_skin_development | 1.13244867 |
| 66 | * MP0002078_abnormal_glucose_homeostasis | 1.12474409 |
| 67 | MP0002420_abnormal_adaptive_immunity | 1.07599789 |
| 68 | * MP0002998_abnormal_bone_remodeling | 1.07445661 |
| 69 | MP0008004_abnormal_stomach_pH | 1.06274419 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.05554620 |
| 71 | MP0000858_altered_metastatic_potential | 1.04722724 |
| 72 | MP0001873_stomach_inflammation | 1.04662754 |
| 73 | MP0005257_abnormal_intraocular_pressure | 1.04455796 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 1.03555250 |
| 75 | MP0002723_abnormal_immune_serum | 1.02839591 |
| 76 | MP0001819_abnormal_immune_cell | 1.01653093 |
| 77 | MP0003950_abnormal_plasma_membrane | 1.01570524 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 1.00164875 |
| 79 | MP0003890_abnormal_embryonic-extraembry | 0.99090188 |
| 80 | * MP0001845_abnormal_inflammatory_respons | 0.98993018 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.98185568 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 0.98061795 |
| 83 | MP0003436_decreased_susceptibility_to | 0.97873870 |
| 84 | MP0010678_abnormal_skin_adnexa | 0.97433248 |
| 85 | MP0009333_abnormal_splenocyte_physiolog | 0.97030279 |
| 86 | MP0010155_abnormal_intestine_physiology | 0.96289743 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.95590040 |
| 88 | MP0005023_abnormal_wound_healing | 0.95384320 |
| 89 | MP0003828_pulmonary_edema | 0.95239396 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.95068772 |
| 91 | MP0002118_abnormal_lipid_homeostasis | 0.94813623 |
| 92 | MP0004381_abnormal_hair_follicle | 0.93680880 |
| 93 | MP0002006_tumorigenesis | 0.93217440 |
| 94 | * MP0002896_abnormal_bone_mineralization | 0.92856607 |
| 95 | MP0002933_joint_inflammation | 0.91392288 |
| 96 | MP0002398_abnormal_bone_marrow | 0.89813482 |
| 97 | MP0003195_calcinosis | 0.89555041 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.89484108 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.88273742 |
| 100 | MP0002132_abnormal_respiratory_system | 0.87940342 |
| 101 | MP0001915_intracranial_hemorrhage | 0.86993391 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.84632872 |
| 103 | MP0002060_abnormal_skin_morphology | 0.83597455 |
| 104 | MP0000716_abnormal_immune_system | 0.83455641 |
| 105 | MP0010329_abnormal_lipoprotein_level | 0.83444393 |
| 106 | MP0001853_heart_inflammation | 0.82677864 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.82276948 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.82050352 |
| 109 | MP0000462_abnormal_digestive_system | 0.80764142 |
| 110 | MP0005623_abnormal_meninges_morphology | 0.80087314 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.79633727 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.79232055 |
| 113 | * MP0003795_abnormal_bone_structure | 0.78764315 |
| 114 | MP0010307_abnormal_tumor_latency | 0.78739289 |
| 115 | MP0003959_abnormal_lean_body | 0.78652093 |
| 116 | MP0001849_ear_inflammation | 0.78610820 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.76045780 |
| 118 | MP0009115_abnormal_fat_cell | 0.75902019 |
| 119 | MP0000350_abnormal_cell_proliferation | 0.75519315 |
| 120 | MP0009703_decreased_birth_body | 0.75134618 |
| 121 | MP0001851_eye_inflammation | 0.74002932 |
| 122 | MP0008007_abnormal_cellular_replicative | 0.73621033 |
| 123 | MP0003763_abnormal_thymus_physiology | 0.73170594 |
| 124 | MP0005670_abnormal_white_adipose | 0.72200998 |
| 125 | MP0001299_abnormal_eye_distance/ | 0.72153225 |
| 126 | MP0005381_digestive/alimentary_phenotyp | 0.72120700 |
| 127 | MP0000490_abnormal_crypts_of | 0.72023790 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.71783739 |
| 129 | MP0002086_abnormal_extraembryonic_tissu | 0.71556455 |
| 130 | MP0006082_CNS_inflammation | 0.70839236 |
| 131 | * MP0005621_abnormal_cell_physiology | 0.70620687 |
| 132 | MP0002876_abnormal_thyroid_physiology | 0.70414739 |
| 133 | MP0001756_abnormal_urination | 0.69577077 |
| 134 | MP0001663_abnormal_digestive_system | 0.68885538 |
| 135 | MP0002405_respiratory_system_inflammati | 0.68188479 |
| 136 | MP0009840_abnormal_foam_cell | 0.68077514 |
| 137 | MP0002088_abnormal_embryonic_growth/wei | 0.67423654 |
| 138 | MP0001191_abnormal_skin_condition | 0.67078513 |
| 139 | MP0003077_abnormal_cell_cycle | 0.66987117 |
| 140 | MP0002419_abnormal_innate_immunity | 0.66916686 |
| 141 | MP0005164_abnormal_response_to | 0.66691602 |
| 142 | MP0004782_abnormal_surfactant_physiolog | 0.66677303 |
| 143 | MP0000371_diluted_coat_color | 0.66525914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgA deficiency (HP:0002720) | 3.75541686 |
| 2 | Papilloma (HP:0012740) | 3.34502430 |
| 3 | Verrucae (HP:0200043) | 3.34502430 |
| 4 | Agammaglobulinemia (HP:0004432) | 3.23192176 |
| 5 | Recurrent sinusitis (HP:0011108) | 3.11888391 |
| 6 | Cellulitis (HP:0100658) | 3.09838795 |
| 7 | Macroorchidism (HP:0000053) | 3.09583793 |
| 8 | Chronic diarrhea (HP:0002028) | 3.08907367 |
| 9 | Cerebral aneurysm (HP:0004944) | 3.08545227 |
| 10 | Autoimmune hemolytic anemia (HP:0001890) | 3.05098709 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.99578661 |
| 12 | Mucopolysacchariduria (HP:0008155) | 2.99578661 |
| 13 | Thyroiditis (HP:0100646) | 2.89561173 |
| 14 | Colitis (HP:0002583) | 2.87095470 |
| 15 | Tetraparesis (HP:0002273) | 2.85634493 |
| 16 | Mitral stenosis (HP:0001718) | 2.84362707 |
| 17 | Recurrent viral infections (HP:0004429) | 2.83542869 |
| 18 | Dysostosis multiplex (HP:0000943) | 2.80965875 |
| 19 | Abnormality of B cell number (HP:0010975) | 2.76866516 |
| 20 | B lymphocytopenia (HP:0010976) | 2.76866516 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 2.75232151 |
| 22 | T lymphocytopenia (HP:0005403) | 2.74539833 |
| 23 | Aortic aneurysm (HP:0004942) | 2.72746965 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.72719711 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.72719711 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.72719711 |
| 27 | Eosinophilia (HP:0001880) | 2.66400218 |
| 28 | Mitral valve prolapse (HP:0001634) | 2.63539923 |
| 29 | Biliary tract neoplasm (HP:0100574) | 2.60293755 |
| 30 | Vasculitis (HP:0002633) | 2.60293479 |
| 31 | Hypoglycemic seizures (HP:0002173) | 2.57713283 |
| 32 | Subacute progressive viral hepatitis (HP:0006572) | 2.52427659 |
| 33 | Asymmetry of the thorax (HP:0001555) | 2.52403420 |
| 34 | IgG deficiency (HP:0004315) | 2.52042893 |
| 35 | Abnormality of the fingertips (HP:0001211) | 2.51230007 |
| 36 | Abnormality of T cell number (HP:0011839) | 2.48780385 |
| 37 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.47105628 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 2.46764319 |
| 39 | Inflammation of the large intestine (HP:0002037) | 2.46002376 |
| 40 | Papillary thyroid carcinoma (HP:0002895) | 2.40836683 |
| 41 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.40179558 |
| 42 | Hypoplasia of the thymus (HP:0000778) | 2.38283287 |
| 43 | Severe combined immunodeficiency (HP:0004430) | 2.36764118 |
| 44 | Overlapping toe (HP:0001845) | 2.36403545 |
| 45 | Increased CSF protein (HP:0002922) | 2.34702672 |
| 46 | Abnormality of T cells (HP:0002843) | 2.34636922 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 2.34017359 |
| 48 | Curly hair (HP:0002212) | 2.32724169 |
| 49 | Flat acetabular roof (HP:0003180) | 2.30935553 |
| 50 | Myocardial infarction (HP:0001658) | 2.30516500 |
| 51 | Ulnar bowing (HP:0003031) | 2.29664598 |
| 52 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.29322706 |
| 53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.28641395 |
| 54 | Basal cell carcinoma (HP:0002671) | 2.27503465 |
| 55 | Thoracolumbar scoliosis (HP:0002944) | 2.26943659 |
| 56 | Granulocytopenia (HP:0001913) | 2.25295788 |
| 57 | Syringomyelia (HP:0003396) | 2.24615620 |
| 58 | Spinal cord lesions (HP:0100561) | 2.24615620 |
| 59 | Papilledema (HP:0001085) | 2.21769933 |
| 60 | Combined immunodeficiency (HP:0005387) | 2.19702386 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.19551751 |
| 62 | Bronchitis (HP:0012387) | 2.17248563 |
| 63 | Arterial tortuosity (HP:0005116) | 2.13502386 |
| 64 | Dilatation of the ascending aorta (HP:0005111) | 2.13423955 |
| 65 | Disproportionate tall stature (HP:0001519) | 2.13401716 |
| 66 | Lymphoma (HP:0002665) | 2.12709833 |
| 67 | Fatigue (HP:0012378) | 2.12510217 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 2.11348144 |
| 69 | * Abnormality of endocrine pancreas physiology (HP:0012093) | 2.10289770 |
| 70 | * Abnormality of the pancreatic islet cells (HP:0006476) | 2.10289770 |
| 71 | Ankyloglossia (HP:0010296) | 2.09064846 |
| 72 | Eczematoid dermatitis (HP:0000976) | 2.08480948 |
| 73 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.08013334 |
| 74 | Severe short stature (HP:0003510) | 2.07437194 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.05908213 |
| 76 | Deep philtrum (HP:0002002) | 2.05011172 |
| 77 | Recurrent lower respiratory tract infections (HP:0002783) | 2.03906257 |
| 78 | Vertebral arch anomaly (HP:0008438) | 2.03666395 |
| 79 | Enlarged penis (HP:0000040) | 2.02336504 |
| 80 | Aneurysm (HP:0002617) | 2.01996529 |
| 81 | Resting tremor (HP:0002322) | 2.00903670 |
| 82 | Symptomatic seizures (HP:0011145) | 2.00814683 |
| 83 | Abnormality of eosinophils (HP:0001879) | 1.99558187 |
| 84 | Recurrent bronchitis (HP:0002837) | 1.99151533 |
| 85 | Fat malabsorption (HP:0002630) | 1.99094175 |
| 86 | Interstitial pulmonary disease (HP:0006530) | 1.98861285 |
| 87 | Hematochezia (HP:0002573) | 1.98765639 |
| 88 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98613267 |
| 89 | Gout (HP:0001997) | 1.96903199 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 1.96821157 |
| 91 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.96821157 |
| 92 | Squamous cell carcinoma (HP:0002860) | 1.96323582 |
| 93 | Lower limb hyperreflexia (HP:0002395) | 1.94591985 |
| 94 | Abnormal biliary tract morphology (HP:0012440) | 1.93524942 |
| 95 | Abnormality of oral frenula (HP:0000190) | 1.90220226 |
| 96 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.88888202 |
| 97 | Emphysema (HP:0002097) | 1.88205762 |
| 98 | Osteomyelitis (HP:0002754) | 1.86322075 |
| 99 | Hyperglycemia (HP:0003074) | 1.85917076 |
| 100 | Cervical subluxation (HP:0003308) | 1.85867075 |
| 101 | Ketoacidosis (HP:0001993) | 1.85862826 |
| 102 | Cutaneous melanoma (HP:0012056) | 1.85523437 |
| 103 | Spondylolisthesis (HP:0003302) | 1.84843105 |
| 104 | IgM deficiency (HP:0002850) | 1.84593833 |
| 105 | Abnormality of macrophages (HP:0004311) | 1.84525123 |
| 106 | * Small epiphyses (HP:0010585) | 1.84504436 |
| 107 | Hepatitis (HP:0012115) | 1.81956027 |
| 108 | Panhypogammaglobulinemia (HP:0003139) | 1.81866009 |
| 109 | Vascular tortuosity (HP:0004948) | 1.81628825 |
| 110 | Vertebral clefting (HP:0008428) | 1.81421679 |
| 111 | Autoimmune thrombocytopenia (HP:0001973) | 1.81377025 |
| 112 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.81364818 |
| 113 | Cubitus valgus (HP:0002967) | 1.81102283 |
| 114 | Viral hepatitis (HP:0006562) | 1.80579659 |
| 115 | Striae distensae (HP:0001065) | 1.80220986 |
| 116 | Somatic mutation (HP:0001428) | 1.78841357 |
| 117 | Recurrent fungal infections (HP:0002841) | 1.78712246 |
| 118 | Abnormality of the gastric mucosa (HP:0004295) | 1.76460010 |
| 119 | Abnormality of the lumbar spine (HP:0100712) | 1.75738433 |
| 120 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.75711797 |
| 121 | Thyroid carcinoma (HP:0002890) | 1.75053605 |
| 122 | Uterine leiomyosarcoma (HP:0002891) | 1.74123996 |
| 123 | Leiomyosarcoma (HP:0100243) | 1.74123996 |
| 124 | Recurrent otitis media (HP:0000403) | 1.74024324 |
| 125 | Lymphopenia (HP:0001888) | 1.73837407 |
| 126 | Sepsis (HP:0100806) | 1.73797274 |
| 127 | Restrictive lung disease (HP:0002091) | 1.72547606 |
| 128 | Hypoglycemic coma (HP:0001325) | 1.72528717 |
| 129 | Abdominal distention (HP:0003270) | 1.71853088 |
| 130 | Bladder neoplasm (HP:0009725) | 1.71473114 |
| 131 | Bladder carcinoma (HP:0002862) | 1.71473114 |
| 132 | Pulmonary infiltrates (HP:0002113) | 1.71159955 |
| 133 | Coarse hair (HP:0002208) | 1.69952981 |
| 134 | Hypoproteinemia (HP:0003075) | 1.69365643 |
| 135 | Micronodular cirrhosis (HP:0001413) | 1.68104935 |
| 136 | Hand muscle atrophy (HP:0009130) | 1.68077639 |
| 137 | Abnormality of the prostate (HP:0008775) | 1.66708932 |
| 138 | Xerostomia (HP:0000217) | 1.65639158 |
| 139 | * Exocrine pancreatic insufficiency (HP:0001738) | 1.64944755 |
| 140 | Tibial bowing (HP:0002982) | 1.64905747 |
| 141 | Abnormality of T cell physiology (HP:0011840) | 1.63932269 |
| 142 | Hyperkalemia (HP:0002153) | 1.63676520 |
| 143 | Gastrointestinal carcinoma (HP:0002672) | 1.62490728 |
| 144 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.62490728 |
| 145 | Arterial thrombosis (HP:0004420) | 1.62463643 |
| 146 | Right ventricular cardiomyopathy (HP:0011663) | 1.61818889 |
| 147 | Conjugated hyperbilirubinemia (HP:0002908) | 1.61741073 |
| 148 | Thoracic kyphosis (HP:0002942) | 1.61245937 |
| 149 | Cortical dysplasia (HP:0002539) | 1.61041865 |
| 150 | Steatorrhea (HP:0002570) | 1.60419546 |
| 151 | Abnormality of the peritoneum (HP:0002585) | 1.60208255 |
| 152 | Abnormality of the thoracic spine (HP:0100711) | 1.60139744 |
| 153 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.60125610 |
| 154 | Aortic dissection (HP:0002647) | 1.59588912 |
| 155 | Glomerulosclerosis (HP:0000096) | 1.59565367 |
| 156 | Meningitis (HP:0001287) | 1.58979702 |
| 157 | Lymphedema (HP:0001004) | 1.58974939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.23858830 |
| 2 | PRPF4B | 3.88129362 |
| 3 | MAP3K10 | 3.50734611 |
| 4 | FRK | 3.08815806 |
| 5 | TRIB3 | 2.93864817 |
| 6 | NTRK1 | 2.52501621 |
| 7 | SIK1 | 2.41860441 |
| 8 | TAOK3 | 2.31919406 |
| 9 | NEK9 | 2.28097959 |
| 10 | MAP4K1 | 2.26317483 |
| 11 | GRK6 | 2.25844969 |
| 12 | EEF2K | 2.19429099 |
| 13 | PKN2 | 2.07842913 |
| 14 | MAP3K2 | 1.96946454 |
| 15 | INSRR | 1.92156066 |
| 16 | PTK6 | 1.90021691 |
| 17 | NLK | 1.88281647 |
| 18 | IKBKE | 1.81973790 |
| 19 | CDK12 | 1.75927568 |
| 20 | BMPR2 | 1.74928928 |
| 21 | STK24 | 1.66451010 |
| 22 | JAK1 | 1.56771651 |
| 23 | LRRK2 | 1.52030864 |
| 24 | SIK3 | 1.52022214 |
| 25 | STK10 | 1.51937401 |
| 26 | SCYL2 | 1.50786623 |
| 27 | EPHB1 | 1.44764422 |
| 28 | TRPM7 | 1.44528177 |
| 29 | HIPK2 | 1.37974777 |
| 30 | LATS1 | 1.36238662 |
| 31 | AKT3 | 1.35054150 |
| 32 | TBK1 | 1.34324042 |
| 33 | CAMK1G | 1.30529191 |
| 34 | CAMK1D | 1.28936648 |
| 35 | IKBKB | 1.28373089 |
| 36 | TGFBR2 | 1.25559445 |
| 37 | IRAK4 | 1.19795751 |
| 38 | RIPK4 | 1.19296662 |
| 39 | KSR1 | 1.18691134 |
| 40 | MET | 1.17742963 |
| 41 | ITK | 1.15016196 |
| 42 | YES1 | 1.14673635 |
| 43 | PDGFRB | 1.12952618 |
| 44 | STK38L | 1.12102519 |
| 45 | BLK | 1.11276937 |
| 46 | CSF1R | 1.10086730 |
| 47 | FGFR3 | 1.09826870 |
| 48 | TYK2 | 1.08140629 |
| 49 | FGFR2 | 1.08121896 |
| 50 | BRD4 | 1.05810874 |
| 51 | SMG1 | 1.03073912 |
| 52 | PRKCH | 1.01837921 |
| 53 | FGFR4 | 1.01589084 |
| 54 | MAPK11 | 0.99023481 |
| 55 | BTK | 0.98735857 |
| 56 | IRAK3 | 0.98714592 |
| 57 | MTOR | 0.96894206 |
| 58 | MST4 | 0.95559782 |
| 59 | PDGFRA | 0.94379722 |
| 60 | MAP3K1 | 0.91444105 |
| 61 | CDK6 | 0.89980975 |
| 62 | CDK4 | 0.89578326 |
| 63 | EPHA2 | 0.89566690 |
| 64 | PASK | 0.88200543 |
| 65 | RPS6KB1 | 0.88174800 |
| 66 | MST1R | 0.87146302 |
| 67 | RIPK1 | 0.86051709 |
| 68 | ALK | 0.83544873 |
| 69 | NEK6 | 0.82617284 |
| 70 | BCKDK | 0.82507147 |
| 71 | PIK3CG | 0.80879748 |
| 72 | LATS2 | 0.78908618 |
| 73 | STK39 | 0.78735309 |
| 74 | MAP3K7 | 0.78575591 |
| 75 | PTK2 | 0.77837520 |
| 76 | ZAP70 | 0.77091280 |
| 77 | CSK | 0.76621643 |
| 78 | SGK3 | 0.75039047 |
| 79 | STK3 | 0.74986971 |
| 80 | BMX | 0.74701038 |
| 81 | RET | 0.74679462 |
| 82 | JAK2 | 0.74435556 |
| 83 | HCK | 0.72581397 |
| 84 | CHUK | 0.71979065 |
| 85 | CLK1 | 0.70806364 |
| 86 | EPHA3 | 0.69929538 |
| 87 | MAP3K3 | 0.69860516 |
| 88 | SYK | 0.68864363 |
| 89 | MAPKAPK3 | 0.68734967 |
| 90 | TEC | 0.67014762 |
| 91 | CDC42BPA | 0.65956039 |
| 92 | MARK3 | 0.65514339 |
| 93 | DYRK1B | 0.65187370 |
| 94 | LYN | 0.62596629 |
| 95 | EGFR | 0.60745775 |
| 96 | MAP3K5 | 0.59725435 |
| 97 | PDK1 | 0.59437789 |
| 98 | PDPK1 | 0.59336993 |
| 99 | MAP2K2 | 0.59009887 |
| 100 | IRAK1 | 0.58016745 |
| 101 | PIM1 | 0.57990931 |
| 102 | INSR | 0.57955513 |
| 103 | JAK3 | 0.57390314 |
| 104 | CDK8 | 0.56656223 |
| 105 | MKNK2 | 0.56221644 |
| 106 | TNIK | 0.55483825 |
| 107 | MELK | 0.55405816 |
| 108 | MAPK7 | 0.54515837 |
| 109 | FLT3 | 0.54479726 |
| 110 | PRKCQ | 0.53264739 |
| 111 | PRKD1 | 0.53206342 |
| 112 | SIK2 | 0.50146573 |
| 113 | WNK1 | 0.49505830 |
| 114 | ABL1 | 0.49105820 |
| 115 | STK11 | 0.48615302 |
| 116 | PAK3 | 0.48477382 |
| 117 | CDK9 | 0.48300096 |
| 118 | RAF1 | 0.48189162 |
| 119 | MAPK15 | 0.46783795 |
| 120 | KSR2 | 0.46741583 |
| 121 | MATK | 0.46519316 |
| 122 | SGK494 | 0.46413360 |
| 123 | SGK223 | 0.46413360 |
| 124 | MAP3K9 | 0.45947833 |
| 125 | BRSK2 | 0.44987758 |
| 126 | PIK3CA | 0.43827277 |
| 127 | NUAK1 | 0.43616172 |
| 128 | PRKAA1 | 0.43253802 |
| 129 | MAP3K14 | 0.43196981 |
| 130 | MAP3K13 | 0.42445798 |
| 131 | MAP2K1 | 0.42361633 |
| 132 | MAP3K8 | 0.41848414 |
| 133 | DMPK | 0.41092546 |
| 134 | PRKD2 | 0.40519485 |
| 135 | MOS | 0.40149373 |
| 136 | LCK | 0.40099435 |
| 137 | MARK2 | 0.40022214 |
| 138 | FGR | 0.39545837 |
| 139 | FYN | 0.38568318 |
| 140 | ICK | 0.38483236 |
| 141 | GSK3A | 0.38013813 |
| 142 | RPS6KB2 | 0.37791659 |
| 143 | SGK2 | 0.36502649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.59076642 |
| 2 | Pancreatic secretion_Homo sapiens_hsa04972 | 2.78955418 |
| 3 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.51000335 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.40914168 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.31044747 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.22583663 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.15302209 |
| 8 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.12471058 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11638534 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.00156749 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.98371712 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82167515 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.77225281 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75872750 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.71377385 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69816047 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.67452526 |
| 18 | * Influenza A_Homo sapiens_hsa05164 | 1.64342257 |
| 19 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.64073347 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61121013 |
| 21 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.53963279 |
| 22 | * Measles_Homo sapiens_hsa05162 | 1.53190345 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.50727887 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44287022 |
| 25 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.41861390 |
| 26 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.36657933 |
| 27 | * Apoptosis_Homo sapiens_hsa04210 | 1.34074365 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.32146545 |
| 29 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.31075216 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.28605377 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26969713 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.26208076 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25108007 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21514325 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.17907315 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17033279 |
| 37 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.16193069 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.15222684 |
| 39 | Prostate cancer_Homo sapiens_hsa05215 | 1.14243831 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13633949 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13262146 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.13210702 |
| 43 | Thyroid cancer_Homo sapiens_hsa05216 | 1.13041174 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12081712 |
| 45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.11676257 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11656621 |
| 47 | * Hepatitis C_Homo sapiens_hsa05160 | 1.10021426 |
| 48 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.09727949 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09501596 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08843894 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.08534447 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07420018 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06433483 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.05578066 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03962013 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03226501 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 1.01496177 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 1.01008267 |
| 59 | Glioma_Homo sapiens_hsa05214 | 1.00985431 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96654547 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93480885 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89873923 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87970735 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87696493 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86914037 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86850378 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86360615 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86092671 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85569742 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85137123 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84628188 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83469021 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83252491 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.82903517 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.82314875 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81497499 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79807603 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.79565199 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78276865 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77379870 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77331030 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77252789 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77041797 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76965314 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74815207 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74587625 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.73744904 |
| 88 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72222975 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72029384 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71969373 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71938629 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70605607 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70566521 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.70055306 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.69827252 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68344149 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67137379 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67017077 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65651236 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64303784 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63349642 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63237546 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62716481 |
| 104 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62241549 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61628575 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61509703 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61061566 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60385715 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60341796 |
| 110 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59626876 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.58863338 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57279367 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56818024 |
| 114 | Cocaine addiction_Homo sapiens_hsa05030 | 0.56636519 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55353434 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55200464 |
| 117 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55150932 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.54999184 |
| 119 | Shigellosis_Homo sapiens_hsa05131 | 0.54801766 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53738081 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53097632 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.52516482 |
| 123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52503746 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51749741 |
| 125 | Malaria_Homo sapiens_hsa05144 | 0.51585938 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.51207700 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48407988 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48298721 |
| 129 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47644860 |
| 130 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46333526 |
| 131 | Pertussis_Homo sapiens_hsa05133 | 0.44685731 |
| 132 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42739156 |
| 133 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42202968 |
| 134 | Tuberculosis_Homo sapiens_hsa05152 | 0.41676801 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41431349 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40890685 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40827566 |
| 138 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40194430 |

